These together suggest that although IFNγ can target colorectal cancer stemness, it may hold true for only a small proportion of sporadic colorectal cancer patients, and additional strategies are needed to enhance the sensitivity of colorectal cancer cells carrying APC mutation to IFNγ treatment. This evidence concerns the gene APC and colorectal cancer.